Furthermore, CTS interferes with the interaction between AR and the histone demethylase LSD1, preventing the demethylation of histone H3 at lysine 9 (H3-K9), thus inhibiting AR-mediated gene activation and prostate cancer growth [179]. This evidence concerns the gene AR and prostate carcinoma.